WCM Focused Global Growth Fund OCSE:NOVO B Holdings History
WCM Focused Global Growth Fund's Novo Nordisk AS Holding Summary
As of 2024-09-30, Investment Managers Series Trust held 180,016.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr21.15 Mil. This investment constitutes 4.41% of their stock portfolio, and Investment Managers Series Trust now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2022Q3. And since then WCM Focused Global Growth Fund has made 3 purchases of OCSE:NOVO B, at an average price of kr447.25, for a total of 228,161.00 shares. In addition, there have been 6 sales at an average price of kr553.41 for 48,145.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr443.25, WCM Focused Global Growth Fund's estimated gain on his OCSE:NOVO B holdings is kr4.39 Mil, reflecting a 4.30% gain to date.
WCM Focused Global Growth Fund OCSE:NOVO B (kr443.25) Holding Chart
WCM Focused Global Growth Fund OCSE:NOVO B (kr443.25) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
